Maja Česen
Impact in
-
- Tumors and Oncological Cases
-
- Sarcoma Diagnosis and Treatment
Papers in
-
- Sarcoma Diagnosis and Treatment 7
-
- Tumors and Oncological Cases 4
- Lymphoma Diagnosis and Treatment 2
- Co-authors
- Jürgen Schrader (1 shared paper)Gianni Bisogno (9 shared papers)Janez Jazbec (2 shared papers)Vladimír Soják (1 shared paper)Miomir Knežević (1 shared paper)Andrea Ferrari (6 shared papers)Daniel Orbach (6 shared papers)Lenart Girandon (1 shared paper)
- Journals
- European Journal of Cancer (3 papers)Journal of Clinical Oncology (2 papers)Pediatric Blood & Cancer (2 papers)Cancer (1 paper)Frontiers in Pediatrics (1 paper)
- Partner nations
- SloveniaItalyUnited Kingdom
In The Last Decade
Maja Česen
15 papers receiving 105 citations
Peers
Comparison fields: 5 of 27
- Pathology and Forensic Medicine 30
- Pulmonary and Respiratory Medicine 49
- Rheumatology 16
- Genetics 11
- Oncology 26
Countries citing papers authored by Maja Česen
This map shows the geographic impact of Maja Česen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maja Česen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maja Česen more than expected).
Fields of papers citing papers by Maja Česen
This network shows the impact of papers produced by Maja Česen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maja Česen. The network helps show where Maja Česen may publish in the future.
Co-authors
The 25 scholars most cited alongside Maja Česen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 18 | |
| 2 | 2018 | 15 | |
| 3 | 2021 | 13 | |
| 4 | 2021 | 13 | |
| 5 | 2022 | 11 | |
| 6 | 2024 | 8 | |
| 7 | 2022 | 8 | |
| 8 | 2018 | 6 | |
| 9 | 2024 | 3 | |
| 10 | 2020 | 3 | |
| 11 | 2022 | 3 | |
| 12 | 2025 | 3 | |
| 13 | 2025 | 1 | |
| 14 | 2022 | 1 | |
| 15 | 2022 | 1 | |
| 16 | 2023 | 0 |
About Maja Česen
Maja Česen is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Oncology, Surgery and Pediatrics, Perinatology and Child Health, having authored 16 papers that have together received 107 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (7 papers), Tumors and Oncological Cases (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Childhood Cancer Survivors' Quality of Life (3 papers), Lung Cancer Research Studies (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Soft tissue tumor case studies (1 paper) and Mesenchymal stem cell research (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (30 citations), Pulmonary and Respiratory Medicine (49 citations), Rheumatology (16 citations), Genetics (11 citations) and Oncology (26 citations). Maja Česen has collaborated with scholars based in Slovenia, Italy and United Kingdom. Frequent co-authors include Jürgen Schrader, Gianni Bisogno, Janez Jazbec, Vladimír Soják, Miomir Knežević, Andrea Ferrari, Daniel Orbach, Lenart Girandon, Véronique Minard‐Colin and Johannes H. M. Merks. Their work appears in journals such as European Journal of Cancer, Journal of Clinical Oncology, Pediatric Blood & Cancer, Cancer and Frontiers in Pediatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.